LifeMD
LFMD
53 hedge funds and large institutions have $23.1M invested in LifeMD in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 22 closing their positions.
10% less call options, than puts
Call options by funds: $621K | Put options by funds: $691K
13.32% less ownership
Funds ownership: 32.83% → 19.51% (-13%)
23% less funds holding
Funds holding: 69 → 53 (-16)
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
58% less capital invested
Capital invested by funds: $54.8M → $23.1M (-$31.7M)
64% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$724K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$552K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$473K |
| 4 |
Renaissance Technologies
New York
|
+$468K |
| 5 |
D.E. Shaw & Co
New York
|
+$373K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Ophir Asset Management
Sydney,
Australia
|
-$5.61M |
| 2 |
ACM
Altium Capital Management
New York
|
-$1.79M |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$1.55M |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.45M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.26M |
LFMD Hedge Fund Activity: Q4 2021 in Review
53 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q4 2021, worth a combined $23.1M — down 58% from $54.8M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of LFMD and 8 opened new positions — a net loss of 14 holders — while 23 trimmed existing stakes and 12 added.
The largest buyer was Vanguard Group, adding an estimated $724K. The largest seller was Ophir Asset Management, exiting entirely with an estimated $5.61M sold.
- 53 institutional investors held LifeMD (LFMD) as of Q4 2021, down from 69 in Q3 2021.
- Funds reported $23.1M of LifeMD stock for Q4 2021, down 58% quarter-over-quarter.
- 8 funds opened new LifeMD positions in Q4 2021 and 22 closed out, a net change of -14 holders.
- The largest LifeMD buyer in Q4 2021 was Vanguard Group, an estimated $724K added.
- The largest LifeMD seller in Q4 2021 was Ophir Asset Management, an estimated $5.61M sold.
Based on aggregated 13F filings for Q4 2021.